SEC EDGAR CompanyFacts fact · reporting period
REGENEREX PHARMA, INC: operating_income
One fact, its scope and the complete path back to the official record.
Reported value
$-1.829M{"amount": -1828814, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}- Entity
- REGENEREX PHARMA, INC
- Metric
- operating_income
- Period
- 2024-04-01 – 2025-03-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T13:39:01.869329+02:00
Raw response SHA-256
213194c506fa9441e1992f90b01cc25f…Official-identifier path
https://factanker.com/fact/sec/cik-0001357878/operating-income/2025-03-31 (CIK, metric, reporting date)History
- supersedes {"amount": -1826097, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001472375-25-000070)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.